CDK1 and glioma: Cdk1 (also named Cdc2) and cyclin B1 are also targets of the proteasome as evidenced from a study using geldanamycin, a drug interfering with the function of the chaperone protein Hsp90 (Heat shock protein 90), in glioma cells.